Common variants in β2- and β3-adrenergic receptor genes and uncoupling protein 1 as predictors of the risk for type 2 diabetes and body weight changes. The Finnish Diabetes Prevention Study
- 24 August 2004
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 66 (4) , 365-367
- https://doi.org/10.1111/j.1399-0004.2004.00313.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Genetics and Pathophysiology of Human ObesityAnnual Review of Medicine, 2003
- Gln27Glu β2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liverClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetesDiabetologia, 2001
- Common variants in the β2-(Gln27Glu) and β3-(Trp64Arg) -adrenoceptor genes are associated with elevated serum NEFA concentrations and Type II diabetesDiabetologia, 2001
- Genetic variance and lipolysis regulation: implications for obesity.Annals of Medicine, 2001
- Polymorphisms of the β2‐adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in menJournal of Internal Medicine, 2000
- The Q/E27 polymorphism in the β2‐adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride‐rich lipoproteinsJournal of Internal Medicine, 2000
- Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.Journal of Clinical Investigation, 1997
- GENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUSAnnual Review of Medicine, 1996
- Amino-Terminal Polymorphisms of the Human .beta.2-Adrenergic Receptor Impart Distinct Agonist-Promoted Regulatory PropertiesBiochemistry, 1994